5-alpha-reductase inhibitors for prostate cancer prevention (Q22252970)

7 February 2023

B S

Kramer

Barnett S Kramer

1 reference

7 February 2023

Roderick MacDonald

MacDonald

1 reference

7 February 2023

Karen Hagerty

series ordinal

author given names

author last names

Hagerty

1 reference

7 February 2023

Paul Schellhammer

series ordinal

author given names

author last names

Schellhammer

1 reference

Cochrane Database of Systematic Reviews

7 February 2023

language of work or name

English

0 references

publication date

23 April 2008

0 references

published in

0 references

issue

0 references

page(s)

CD007091

0 references

cites work

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Comparison of tamsulosin and finasteride for lower urinary tract symptoms associated with benign prostatic hyperplasia in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Prostate cancer prevention and finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

inferred from DOI database lookup

7 January 2021

based on heuristic

A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007091

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD007091

0 references

Fatcat ID

release_k4ywe7sr4jfwnktvjbxch7dkvu

0 references